abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

このページは 日本語 では利用できません。English で表示されています

記事

2015年10月11日

著者:
www.pharmaletter.com

India sets out new guidelines for clinical trials with children

The Indian Council of Medical Research has drafted new guidelines on clinical trials with children, stating that the child’s approval would be compulsory in order to take part in any clinical trial...A spate of fatalities among subjects of clinical trials in India, which made international headlines, and the death of 49 children in six clinical trials conducted at India's premier institute, the All India Institute of Medical Sciences (AIIMS) several years ago, proved to be the proverbial last straw and instrumental in moving the Indian government to shake up its rules on clinical trials involving children.